NEO — NEOGENOMICS INC
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1077183 ·
Last close
$15.29
Market Cap
$1.99B
52W High
$16.17
52W Low
$8.18
ADV30
3,507,030
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 201,656,000 | 91,878,000 | -9,771,000 | 2,238,000 | 1,352,243,000 | 145,539,000 | 566,511,000 |
| Mar 2026 | 186,672,000 | 80,864,000 | -18,241,000 | -17,106,000 | 1,346,531,000 | 146,143,000 | 517,771,000 |
| Dec 2025 | 190,170,000 | 83,343,000 | -12,788,000 | -9,881,000 | 1,359,830,000 | 159,618,000 | 523,268,000 |
| Sep 2025 | 187,797,000 | 80,446,000 | -19,928,000 | -27,129,000 | 1,374,780,000 | 164,117,000 | 536,490,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,049,000
Investing CF
$-19,901,000
Financing CF
$-11,386,000
CapEx
$-29,404,000
Dividends Paid
—
Buybacks
$-25,000,000
EPS Diluted TTM
$-0.40
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-450,912,000
Inventory
$29,837,000
Receivables
$167,424,000
ST Investments
$0
EBIT TTM
$-99,456,000
Pretax Income TTM
$-102,189,000
Interest Exp TTM
$2,733,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$766,294,976
EBITDA
$24,325,000
Free Cash Flow
$43,904,752
Enterprise Value
$2,267,218,432
Total Cash
$145,539,008
Total Debt
$448,368,000
Shares Out
130,211,780
Trailing EPS
$-0.39
Book Value
$6.39
ROE
-6.3%
ROA
-1.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 727,332,000 | -88,128,000 | -108,025,000 | 1,359,830,000 | 523,268,000 | — | 5,230,000 |
| Dec 2024 | 660,566,000 | -85,448,000 | -78,726,000 | 1,638,038,000 | 735,699,000 | — | 7,023,000 |
| Dec 2023 | 591,643,000 | -96,648,000 | -87,968,000 | 1,681,229,000 | 739,692,000 | — | -1,953,000 |
| Dec 2022 | 509,728,000 | -153,107,000 | -144,250,000 | 1,740,034,000 | 742,011,000 | — | -65,993,000 |
TTM Snapshot
Revenues TTM
$569,900,000
NetIncome TTM
$-102,777,000
OpCashFlow TTM
$0
Assets (Latest)
$1,638,038,000
Forward EPS
$0.34
Max Pain — expiry 2026-12-18
max pain strike: $10.00 · spot: $15.29 · call oi: 6,866 · put oi: 77Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRDO | PERDOCEO EDUCATION Corp | $1.99B | $31.81 | — |
| GT | GOODYEAR TIRE & RUBBER CO /OH/ | $2.00B | $6.95 | — |
| LUNR | Intuitive Machines, Inc. | $1.98B | $12.34 | — |
| ZD | ZIFF DAVIS, INC. | $1.96B | $53.08 | — |
| BSTZ | BlackRock Science & Technology Term Trust | $1.95B | $28.43 | — |
News headlines (Yahoo Finance, 1h cache)
Why NeoGenomics (NEO) Stock Is Up Today
2026-07-30 09:09 · Yahoo
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
2026-07-30 07:49 · Yahoo
Sector Update: Healthcare Stocks Softer Late Afternoon
2026-07-29 19:46 · Yahoo
NeoGenomics Inc (NEO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ...
2026-07-29 05:02 · Yahoo
NeoGenomics Q2 Earnings Call Highlights
2026-07-28 22:04 · Yahoo
NeoGenomics’s (NASDAQ:NEO) Q2 CY2026: Beats On Revenue
2026-07-28 20:43 · Yahoo
NeoGenomics Reports Second Quarter 2026 Results
2026-07-28 20:05 · Yahoo
NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For
2026-07-27 05:09 · Yahoo
1 Momentum Stock with Solid Fundamentals and 2 We Avoid
2026-07-23 10:30 · Yahoo
NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
2026-07-20 21:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.